These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 3079059)

  • 1. Triple drug therapy: an alternative regimen in renal transplantation.
    Henry ML; Sommer BG; Ferguson RM
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1920-1. PubMed ID: 3079059
    [No Abstract]   [Full Text] [Related]  

  • 2. Pediatric renal transplantation results are improved with triple drug therapy with cyclosporine, azathioprine, and prednisone.
    MacDonell RC; Johnson K; Richie R; Nylander W; McMahon Y; Niblack G; Green W; Morrissey J; Ynares C
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1701-4. PubMed ID: 2652557
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum beta 2 microglobulin levels are relatively depressed in cyclosporine A-treated patients who undergo kidney graft rejection.
    Kootte AM; Henny FC; Moolenaar AJ; van Es LA; Paul LC
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1681-2. PubMed ID: 3079033
    [No Abstract]   [Full Text] [Related]  

  • 4. A flexible immunosuppression protocol for organ transplantation using cyclosporine, azathioprine, and prednisone.
    Schweizer RT; Rovelli M; Roper L; Bartus SA
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1944-6. PubMed ID: 3079062
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of discontinuing or restricting cyclosporine on late renal allograft rejection and function.
    Woodle ES; Heffron TG; Stuart JK; Thistlethwaite JR; Stuart FP
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1641-2. PubMed ID: 2652536
    [No Abstract]   [Full Text] [Related]  

  • 6. Quadruple therapy for cadaver renal transplantation.
    Deierhoi MH; Sollinger HW; Kalayoglu M; Belzer FO
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1917-9. PubMed ID: 3274452
    [No Abstract]   [Full Text] [Related]  

  • 7. Requirements for safe prednisone discontinuation in late renal transplantation in recipients immunosuppressed with cyclosporine.
    Lloveras J; Puig JM; Comerma I; Orfila A; Mir M; Masramón J; Aubia J
    Transplant Proc; 1990 Aug; 22(4):1693-4. PubMed ID: 2202127
    [No Abstract]   [Full Text] [Related]  

  • 8. Early graft function in primary and regraft recipients of paired cadaveric kidneys.
    Jaklitsch MT; Deierhoi MH; Hudson S; Barber WH; Barger BO; Phillips MG; Diethelm AG
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1274-5. PubMed ID: 2652421
    [No Abstract]   [Full Text] [Related]  

  • 9. A controlled trial of azathioprine in combination with cyclosporine in cadaveric renal transplantation.
    Griffin PJ; Ferguson CJ; Ross WB; Salaman JR
    Transplant Proc; 1990 Aug; 22(4):1369. PubMed ID: 2202112
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of triple therapy to minimize cyclosporine (CsA) nephrotoxicity in renal transplantation.
    Landsberg DN; Rae A; Chiu A; Werb R; Taylor P; Chan-Yan C; Manson AD
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1550-1. PubMed ID: 2652502
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclosporin A as sole immunosuppressive agent for renal transplantation in children: effect on catch-up growth.
    Hodson EM; Knight JF; Sheil AG; Roy LP
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1687-92. PubMed ID: 2652553
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclosporine as treatment for corticosteroid-resistant rejection episodes in renal transplantation.
    Garcia VD; Goldani JC; Garcia CD; Cantisani GP; Losekann A; Messias A; Mattos DB; Vitola SP; Bianchini JJ
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1643-5. PubMed ID: 2652537
    [No Abstract]   [Full Text] [Related]  

  • 13. Experience with cyclosporine and prednisone as immunosuppressants in 36 renal transplants.
    Kovithavongs T; Boake R; Lakey WH; Ulan RA; Dossetor JB
    Transplant Proc; 1984 Aug; 16(4):1083-5. PubMed ID: 6380055
    [No Abstract]   [Full Text] [Related]  

  • 14. Triple immunosuppressive therapy in immunologic high-risk renal allograft recipients.
    Cole E; Robinson C; Bear R
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2026-7. PubMed ID: 2652662
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of azathioprine, cyclosporine, and steroids on the graft and on cytologic patterns of rejection.
    Häyry P; von Willebrand E; Ahonen J; Eklund B; Salmela K; Höckerstedt K; Pettersson E; Koskimies S
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1650-1. PubMed ID: 3079031
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of triple therapy on cyclosporine nephrotoxicity and hypertension in renal transplantation.
    Landsberg D; Rae A; Chiu A; Werb R; Taylor P; Chan-Yan C; Manson AD
    Transplant Proc; 1989 Apr; 21(2):3323-4. PubMed ID: 2652826
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of renal biopsies in cyclosporine and conventionally immunosuppressed renal transplant recipients.
    Simonton SC; Sibley RK; Fryd DS
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1790. PubMed ID: 3079038
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclosporine-steroids versus conventional therapy in cadaver kidney transplantation: analysis of a randomized trial at two years.
    Gianello P; Squifflet JP; Pirson Y; Stoffel M; Dereme T; Alexandre GP
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1867-72. PubMed ID: 3547891
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of duration of MALG therapy in a quadruple immunosuppressive protocol.
    Stratta RJ; D'Alessandro AM; Armbrust MJ; Pirsch JD; Sollinger HW; Kalayoglu M; Belzer FO
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1726-8. PubMed ID: 2652564
    [No Abstract]   [Full Text] [Related]  

  • 20. A controlled trial of triple therapy in renal transplantation.
    Salaman JR; Griffin PJ; Ross WB; Williams JD
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1935-6. PubMed ID: 3079061
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.